Rightslink® by Copyright Clearance Center

Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Author:

Nitin Jain,Michael J Keating,Philip A. Thompson,Alessandra Ferrajoli,Jan A. Burger,Gautam M. Borthakur,Koichi Takahashi,Zeev E. Estrov,Nathan H. Fowler,Tapan M. Kadia,Marina Y Konopleva,Yesid Alvarado,Musa Yilmaz,Courtney D. DiNardo,Prithviraj Bose et al.

Publication:

Blood

Publisher:

Elsevier

Date:

13 November 2019

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.